Presepsin as a Sepsis Biomarker

PHARMACOECONOMICS. Modern pharmacoeconomics and pharmacoepidemiology
doi 10.17749/2070-4909.2018.11.1.064-070
Full Text
Abstract

Available in full text

Date
Authors
Publisher

IRBIS

Related search

Diagnostic Value of Presepsin in Sepsis

Biomarkers and Applications
2017English

Presepsin and Procalcitonin - Markers of Sepsis and Severe Pneumonia

Bulletin of Medical Science
2017English

Accuracy of Presepsin in Sepsis Diagnosis: A Systematic Review and Meta-Analysis

PLoS ONE
Multidisciplinary
2015English

Presepsin as a New Marker for Early Detection Neonatal Sepsis in Al-Quwayiyah General Hospital Riyadh, KSA

Journal of Advances in Microbiology
2020English

Utility of Presepsin (sCD14-ST) as a Diagnostic and Prognostic Marker of Sepsis in the Emergency Department

Clinica Chimica Acta
MedicineBiochemistryClinical Biochemistry
2015English

Using of TLR2 and TLR4 as Biomarker of Sepsis Severity Detection

Al-Mustansiriyah Journal of Science
2018English

Histidine-Rich Glycoprotein as an Excellent Biomarker for Sepsis and Beyond

Critical Care
Critical CareIntensive Care Medicine
2018English

Use of Procalcitonin as a Biomarker for Sepsis in Moderate to Major Paediatric Burns

Trauma
SurgeryCritical CareEmergency MedicineIntensive Care Medicine
2018English

Evaluation of Serum NT-pCNP as a Diagnostic and Prognostic Biomarker for Sepsis in Dogs

Journal of Veterinary Internal Medicine
MedicineVeterinary
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy